Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Plural Heterocyclic Compounds
(AREA)
Abstract
The novel optically pure compounds, i.e. the single enantiomeric compounds(+)- 5- fluoro-2- [4-cyclopropylmethoxy -2 pyridinyl) methyl] sulfinyl] 1H- benzimidazole and (-) 5- fluoro -2- [4-cycloprpylmethoxy -2- pyridinyl) methyl] sulfinyl] 1H- benzimidazole or a therapeutically acceptable salt thereof, such as Na+, Mg2+, Li+, Ca2+ and N+ ( R) 4 salt , where R is an alkyl group with 1-4 carbon atoms , process for the preparation thereof and pharmaceutical preparations containing the compounds as active ingredients, as well as the used of the compounds in pharmaceutical preparation and intermediates obtained by preparing the compounds.
4-fluoro-2-//(4-methoxy-2-pyridyl)methyl/sulfinyl/ -1h - benzimidazole, process for its production and a pharmaceutical comprising said compound as an active component
Substituted derivatives of 20,21-dinoreburanamenine,their preparation process and the new intermediates thus obtained,their use as medicaments and the pharmaceutical compositions containing them